A delegation from Ghana recently concluded a trade and study mission to Vermont, United States, to gather practical insights into establishing a regulated low-THC cannabis industry. The visit aimed to inform the operationalisation of Ghana’s legal framework for industrial hemp and medicinal cannabis, focusing on robust Ghanaian cannabis regulation.
The Vermont Study Mission
Organised by the Chamber of Cannabis Industry Ghana, the mission was led by CEO Dr. Mark G. Darko, accompanied by Advocacy Committee Chairperson Ms. Akofa Edjeani and Head of Business Development Mr. Jeffrey Sarpong. The team participated in the New England Cannabis Convention (NECANN) in Vermont, engaging in panel sessions and presenting Ghana’s potential for investment in industrial hemp and medicinal cannabis, according to a report by News Ghana.
The delegation undertook site visits to various cannabis nurseries, dispensaries, greenhouse facilities, and cultivation farms in Burlington and Montpelier. These visits provided direct observation of operational models, compliance procedures, and sustainable production methods within an established regulatory environment, offering practical insights for Ghana’s developing industry.
A central component of the mission involved a courtesy call on the Vermont Cannabis Control Board. Discussions focused on key aspects critical for establishing a new market, including:
- The development and implementation of robust regulatory frameworks.
- Strategies for effective stakeholder participation across the industry.
- The importance of public education initiatives concerning cannabis use and regulation.
- Mechanisms to help ensure equitable farmer inclusion throughout the entire value chain, from cultivation to distribution.
Separately, Vermont State University expressed interest in supporting Ghana through research partnerships, capacity building, and knowledge exchange in cannabis-related studies, indicating potential for academic collaboration.
Ghana’s Evolving Regulatory Framework
Ghana revised its narcotics legislation in 2020 with the enactment of the Narcotics Control Commission Act, 2020 (Act 1019), supported by Legislative Instrument (L.I.) 2475. This legislative action permits the cultivation of cannabis varieties with a Tetrahydrocannabinol (THC) content not exceeding 0.3 percent. The permissible uses are strictly for industrial and medicinal purposes, operating under specific regulatory conditions. This framework is central to the development of effective Ghanaian cannabis regulation, establishing clear boundaries for legal operations.
Since the implementation of this legislation, the Narcotics Control Commission (NCC) has initiated the process for license applications. These applications are open across 11 distinct segments of the cannabis value chain, designed to cover the entire lifecycle of the product. These segments include, but are not limited to:
- Cultivation of compliant cannabis varieties.
- Processing raw material into various products.
- Transportation logistics for regulated substances.
- Research and development activities.
- Secure storage facilities.
- Export operations to international markets.
This comprehensive approach aims to establish a structured and controlled industry from production to market, building on earlier coverage by Hemp Gazette regarding Ghana’s collaboration with Vermont to develop its low-potency cannabis marketplace.
Industry Perspectives and Strategic Objectives
Industry stakeholders in Vermont, including representatives from Cambridge Cannabis Company and the Vermont Growers Association, provided insights into the operational aspects of a regulated market. They underscored the importance of transparent regulation, consistent compliance standards, and market structures designed to reflect the shared interests of both farmers and investors.
The Ghanaian delegation stated that the mission’s primary objective was to apply lessons learned from Vermont’s regulated ecosystem. This strategic transfer of knowledge is intended to strengthen Ghana’s investment climate, enhance agricultural productivity, expand export opportunities, and generate employment as the nation’s cannabis industry continues to develop under its new regulatory provisions.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
